Molecular structure pattern

Depression Disease Summary

Overview

Depression is defined as a mood state indicating the absence of a positive affect. It is further defined in the Introduction section.

Depression has affected an estimated 5% of adults worldwide. A more detailed discussion on the prevalence of depression can be found in the Epidemiology section.

Multiple factors affect a person’s mood state. Effects of neurotransmitter level changes in the brain and its role in mood regulation in depression is said to be one of the factors and is discussed in the Pathophysiology section.

The Risk Factors section discusses the interaction of the different factors that predispose patients to depression such as life events and biological factors.

History and Physical Examination

The Clinical Presentation and History sections enumerate the signs and symptoms of depression that will aid in properly diagnosing depression.

Diagnosis

The DSM-5 diagnostic criteria is the main tool used in diagnosing depression. This criteria and other assessment tools are in the Diagnosis or Diagnostic Criteria section.

The psychiatric and general medical disorders that can overlap with the signs and symptoms of depression are enumerated in the Differential Diagnosis section.

Management

The goals of treatment and factors to consider in choosing a treatment modality (eg psychotherapy, pharmacologic therapy, neurostimulation therapy, etc) to be in a patient with depression are listed in the Principles of Therapy section.

Various therapeutic agents that can be used in the management of depression are in the Pharmacological Therapy section. Some examples include selective serotonin reuptake inhibitors (SSRIs), noradrenaline reuptake inhibitor (NRI), and serotonin and norepinephrine reuptake inhibitors (SNRIs).  

Supportive care and the different types of psychotherapy, neurostimulation therapy and chronotherapy that can be employed in patients with depression are discussed in detail in the Nonpharmacological section.

Patient monitoring is an important part of the management of depression. Frequency of follow up and monitoring of patients with depression is discussed in the Monitoring section.

Frequently Asked Questions

When should depression be suspected clinically?
Depression should be suspected even when depressed mood is not the main complaint. Somatic symptoms may predominate, including unexplained fatigue, gastrointestinal distress, back pain, persistent pain, anxiety, or substance abuse. These presentations require careful mood and functional assessment. Read more 
How is depression diagnosed in practice?
Depression is diagnosed using DSM-5 TR diagnostic criteria. Assessment should also include severity, previous depressive episodes, symptom duration and course, functional impairment, and disability. Clinical judgment is required when symptoms occur after significant loss, considering history and cultural context for grief. Read more
When is psychotherapy preferred in depression?
Psychotherapy is an initial treatment choice for mild to moderate major depressive disorder. It is also preferred for pregnant patients or those planning pregnancy. Psychotherapy may be combined with antidepressants in moderate to severe depression, partial response, or adherence problems. Read more
How should antidepressants be selected and titrated?
Antidepressant selection should consider adverse-effect profile, previous patient or family response, patient preference, cost, comorbidities, concurrent medicines, and overdose risk. Treatment should start at a low dose and be titrated gradually to a therapeutic dose. Dose adjustment or switching may be needed for adverse effects. Read more
How should depression treatment be monitored?
Follow-up should monitor response to therapy, adverse drug effects, residual symptoms, functional recovery, adherence, and safety risks. Ongoing review helps determine whether treatment should be continued, adjusted, intensified, or combined with additional psychological or specialist interventions. Read more